Finance

Lists
CHEOY:OTCMKTS
Cochlear Ord ADR
$ 44.75
-0.65%
(-0.29) 1D
10-р сарын 14, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CHEOY...
Open
$ 44.90
High
$ 45.16
Low
$ 44.72
Mkt. cap
8.36 тэрбум
Avg. vol.
21.49 мян
Volume
14.86 мян
52-wk high
$ 98.49
52-wk low
$ 31.82
Beta
0.68
Shares outstanding
130.80 сая
No. of employees
5 мян
Open
$ 44.90
High
$ 45.16
Low
$ 44.72
Mkt. cap
8.36 тэрбум
Avg. vol.
21.49 мян
Volume
14.86 мян
52-wk high
$ 98.49
52-wk low
$ 31.82
Beta
0.68
Shares outstanding
130.80 сая
No. of employees
5 мян
News stories
From web sources and news partners
Profile
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015. Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
About Cochlear Ord ADR
CEODig Howitt
Employees5.4 мян
Founded1981
HeadquartersСидней, Шинэ Өмнөд Вэльс, Австрали
Sector-
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
583.60 сая
583.60 сая
590.20 сая
590.20 сая
Cost of goods sold
159.60 сая
159.60 сая
184.40 сая
184.40 сая
Cost of revenue
159.60 сая
159.60 сая
184.40 сая
184.40 сая
Research and development expenses
76.40 сая
76.40 сая
85.20 сая
85.20 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
224.70 сая
224.70 сая
239.40 сая
239.40 сая
Operating expense
297.85 сая
297.85 сая
321.20 сая
321.20 сая
Total operating expenses
457.45 сая
457.45 сая
505.60 сая
505.60 сая
Operating income
126.15 сая
126.15 сая
84.60 сая
84.60 сая
Other non operating income
-
-
-
-
EBT including unusual items
106.55 сая
106.55 сая
400.00 мян
400.00 мян
EBT excluding unusual items
128.25 сая
128.25 сая
86.55 сая
86.55 сая
Income tax expense
25.80 сая
25.80 сая
7.50 сая
7.50 сая
Effective tax rate
24.21%
24.21%
1,875.00%
1,875.00%
Other operating expenses
-3.25 сая
-3.25 сая
-3.40 сая
-3.40 сая
Net income
80.75 сая
80.75 сая
-7.10 сая
-7.10 сая
Net profit margin
13.84%
13.84%
-1.20%
-1.20%
Earnings per share
-
-
-
-
Interest and investment income
4.20 сая
4.20 сая
900.00 мян
900.00 мян
Interest expense
-3.15 сая
-3.15 сая
-3.45 сая
-3.45 сая
Net interest expenses
1.05 сая
1.05 сая
-2.55 сая
-2.55 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
151.95 сая
151.95 сая
88.00 сая
88.00 сая
Gain or loss from assets sale
-
-
5.80 сая
5.80 сая
AI content may include mistakes. Learn more
Google аппс